Elly Mackay Blog

Inspire Medical Systems Launches New Brand Identity and Website 0

Inspire Medical Systems Launches New Brand Identity and Website

Inspire Medical Systems Inc, a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), recently revealed its new brand identity and launched a new website.

“While our name and focus on patient outcomes remain the same, our brand identity and website, InspireSleep.com, have evolved to ensure prospective patients can easily learn about our innovative sleep apnea treatment,” says Tim Herbert, president and CEO of Inspire Medical Systems, in a release. “Our updated website improves patient education by encouraging website visitors to learn more about Inspire therapy and connect with an Inspire trained medical professional.”

Martin Abrams, vice president of marketing and customer experience, says, “Our focus is on building meaningful and emotional connections. When people struggling with CPAP visit our website, they will find answers to their questions and be able to connect with a medical professional to learn more about our innovative treatment option.”

A new advertising campaign called, “A Button,” also launched in conjunction with the new website. This campaign, which will feature TV,

VirtuOx Seeks to Acquire Substantially All Assets of NovaSom 0

VirtuOx Seeks to Acquire Substantially All Assets of NovaSom

On Aug 2, 2019, NovaSom Inc sought relief from its creditors under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. NovaSom is a provider of home sleep apnea testing, utilizing its AccuSom home sleep test.

On that same date, NovaSom filed with the Bankruptcy Court various pleadings, including a motion to sell substantially all of the assets of NovaSom to VirtuOx Inc, subject to higher and better bids, under a court-supervised process designed to, among other things, maintain the operations of NovaSom and transfer them to an approved purchaser, free and clear of all liens, claims, and encumbrances.

At a hearing on Aug 8, the Bankruptcy Court entered numerous orders authorizing NovaSom to continue its operations, fund its payroll and other working capital needs, and thereby preserve and maintain its business, customer relationships, and goodwill, with an anticipated sale date by September 27, 2019.

If VirtuOx is selected as the highest and best bidder and its purchase contract is approved by the Bankruptcy Court, it is the intention of VirtuOx to

How to Get Sleep Apnea Patients into Well-Fitting Interfaces… Remotely 0

How to Get Sleep Apnea Patients into Well-Fitting Interfaces… Remotely

As fewer patients come into sleep labs for mask fittings and titration studies, telemedicine experts and manufacturers share 6 tips for selecting the correct PAP mask the first time.

When people who suspect they have a sleep disorder live far from the nearest sleep medicine clinic, they may turn to telemedicine providers. These days, even patients who do an in-person initial visit may have subsequent visits handled remotely—such as a diagnosis via home sleep test, followed by auto-CPAP titration. But how do you ensure patients are matched properly to their PAP interfaces, when you don’t have the luxury of an in-person fitting?

There are a growing number of options to make sure that remote patients get an interface that fits, on the first try.

1. Look to CPAP Mask Starter Packs

Several CPAP suppliers have mask starter packs available, which often come with three to four cushion sizes. These packs enable patients to try each cushion size, without ever having to coming into an office, to find the one that works the best for them.

“The starter

Type 2 Diabetes Link to Sleep Problems Confirmed in Midlife Women 0

Type 2 Diabetes Link to Sleep Problems Confirmed in Midlife Women

Hormone changes are known to alter insulin sensitivity and glucose metabolism, as well as interfere with women’s sleep patterns. But little was known about the association between diabetes and sleep disturbances during the menopause transition until now, as a new study concludes that women with diabetes are at greater risk for sleep disturbances. Study results are published online in Menopause, the journal of The North American Menopause Society (NAMS).

Estrogen and progesterone are known to influence cell response to insulin. As a result, it has been suspected that the hormone changes of the menopause transition could cause fluctuations in a woman’s blood sugar levels, putting her at greater risk of diabetes. Statistically, midlife women have a higher prevalence rate of type 2 diabetes during the menopause transition.

Similarly, hormone changes have been shown to affect a woman’s quality of sleep. Mainly because of night sweats and hot flashes caused by hormone changes, about 42% of premenopausal and 60% of postmenopausal women reportedly have sleep disturbances. For those with diabetes, sleep difficulties could be worsened by various diabetes symptoms and

Have Snoring…Will Treat It 0

Have Snoring…Will Treat It

There is no gold standard treatment for snoring—yet—but clinicians and patients have a growing menu of options that can cover most of its causes.

While occasional snoring is a nuisance, chronic snoring can have serious effects on sleep, relationships, and cardiac health—even if not tied to sleep apnea.

Research led by Per Stal, associate professor and research leader at the Department of Integrative Medical Biology at Sweden’s Umeå University, has identified that snoring causes significant long-term injuries, including developing swallowing dysfunction and making patients more susceptible to developing obstructive sleep apnea (OSA). His research notes that snorers and sleep apnea patients have neuromuscular injuries in the upper respiratory tract both at the structural and molecular levels. Recurrent snoring doesn’t allow for these damaged tissues to heal.1

What’s more, preliminary research led by Adrian Curta, MD, a radiology resident at Munich University Hospital in Germany, has identified that women who snore are at much greater cardiac risk than men.2 “It is unfortunately still unclear why women are more susceptible to developing cardiac-related symptoms,” Curta says. He

A Reader Sounds the Sleeplessness Alarm on a Public Safety Issue 0

A Reader Sounds the Sleeplessness Alarm on a Public Safety Issue

I love hearing from readers who respond to my articles with questions, comments, and sleep stories of their own. My readers make up an incredibly bright, thoughtful community, with a lot of strong opinions and a lot of motivation to harness the power of sleep for mind-body health.

Your emails, tweets, and messages stand out for all sorts of reasons—they’re curious, thought-provoking, sometimes funny. And then, every so often, I get a message that sends a chill down my spine, as I did with the one I’m about to share with you.

Let me be clear: I don’t know this reader’s identity. This person wrote to me under complete anonymity. But what he says has the ring of truth, in alignment with the scientific evidence on shift work, sleep, and circadian rhythms. Here’s part of the note:  

I work as an air traffic controller, and I’m curious how much you know about our schedule and if you’ve ever specifically studied it or been asked to comment on it. We work what are known as “Rattlers”, which is a varying schedule

What Traits Predict Whether an Oral Appliance Will Lower AHI? Here Are Five That Appear Promising. 0

What Traits Predict Whether an Oral Appliance Will Lower AHI? Here Are Five That Appear Promising.

Certain traits may define a type of obstructive sleep apnea (OSA) that can be effectively treated with an oral appliance, according to new research published online in the Annals of the American Thoracic Society.

Continuous positive airway pressure, or CPAP, is considered the gold standard for preventing the obstruction by blowing air through a mask into the nose and throat. However, many patients have trouble sleeping with CPAP. For these patients, an oral appliance that moves the lower jaw forward to prevent the periods of obstructed airflow is often an alternative.

In “Polysomnographic Endotyping to Select Obstructive Sleep Apnea Patients for Oral Appliances,” Ahmad A. Bamagoos and colleagues identify five traits that appear to determine the effectiveness of an oral appliance in treating OSA.

“Sleep apnea is not all the same, but we only recently developed ways to look at a sleep study and determine what traits cause the condition in different patients,” says senior author Scott Sands, PhD, assistant professor of medicine at Harvard Medical School and Brigham and Women’s Hospital in Boston, in a release.

George Shultz Innovation Fund Invest in Anapneo Therapeutics at Its Spring Finals 0

George Shultz Innovation Fund Invest in Anapneo Therapeutics at Its Spring Finals

Anapneo Therapeutics will be awarded $250,000 to continue its work towards enabling an investigational new drug application and begin Phase I clinical trials for a compound designed to target a mechanism of respiratory regulation, treating both obstructive and central sleep apneas.

“This investment process provides a compelling opportunity for experiential learning to our students that participate as venture associates,” said Scott Meadow, clinical professor of entrepreneurship and member of the Shultz Innovation Fund Steering Committee. “The caliber of their work and level of professionalism in their presentations to the advisory committee is representative of the program’s growth and impact across our campus.”

from Sleep Review http://www.sleepreviewmag.com/2019/08/george-shultz-innovation-fund-invest-in-anapneo-therapeutics-at-its-spring-finals/…

George Shultz Innovation Fund Invest in Anapneo Therapeutics at Its Spring Finals 0

George Shultz Innovation Fund Invest in Anapneo Therapeutics at Its Spring Finals

Anapneo Therapeutics will be awarded $250,000 to continue its work towards enabling an investigational new drug application and begin Phase I clinical trials for a compound designed to target a mechanism of respiratory regulation, treating both obstructive and central sleep apneas.

“This investment process provides a compelling opportunity for experiential learning to our students that participate as venture associates,” said Scott Meadow, clinical professor of entrepreneurship and member of the Shultz Innovation Fund Steering Committee. “The caliber of their work and level of professionalism in their presentations to the advisory committee is representative of the program’s growth and impact across our campus.”

from Sleep Review http://www.sleepreviewmag.com/2019/08/george-shultz-innovation-fund-invest-in-anapneo-therapeutics-at-its-spring-finals/…

Investigating Personalized Nutrition for Sleep Disorders 0

Investigating Personalized Nutrition for Sleep Disorders

Personalized nutrition company Viome and the Mayo Clinic are collaborating to better understand the role of nutrition in disease and to explore the potential of Viome’s artificial intelligence (AI)-driven personalized diets in helping manage sleep disorders such as sleep apnea and obesity.

The study will focus on measures of obesity (including body fat percent), metabolism (HbA1c), and sleep. The teams will leverage Mayo Clinic’s medical expertise and Viome’s proprietary microbiome analysis platform. Together, they will enable a better understanding of how nutrition affects chronic diseases and explore the effectiveness of personalized nutrition as a strategy to help in treatment, and possibly even prevention, of these diseases.

“Everything we do at Viome is in an effort to create a world where illness is optional. This partnership is no exception,” says Naveen Jain, CEO and founder of Viome, in a release. “Through this collaboration with Mayo Clinic, an iconic organization committed to providing the best patient care, we will be able to amplify the critical importance of personalized nutrition and its direct impact on people suffering from obesity and sleep disorders.”

This